Seattle Children’s Research Institute Creating ‘On-ramp to Biotech’ for Early Career Scientists

Seattle Children’s Research Institute today announced the Invent at Seattle Children’s Postdoctoral Scholars Program, a $45 million investment in training early career scientists historically underrepresented in biotech in the development of therapeutics for childhood conditions. Seattle Children’s has pledged to raise an additional $10 million for the program. “We want to create an on-ramp to […]

Read More →

Five Years After Her Brain Tumor Surgery, Liesel Is Graduating From Harvard

As a high school freshman, Liesel Von Imhof had a dream of attending college at Harvard. She packed her schedule with challenging classes and participated in varsity sports such as cross-country running and cross-country skiing. She had occasional, debilitating headaches that sometimes caused her to miss school, but she blamed them on stress, dehydration or […]

Read More →

Cancer Research at Seattle Children’s Contributes to FDA Approval of CAR T-Cell Immunotherapy Treatment for Adults with Relapsed or Refractory Large B-Cell Lymphoma

The U.S. Food and Drug Administration on Feb. 5 approved Bristol Myers Squibb’s Breyanzi, a chimeric antigen receptor (CAR) T-cell therapy used to treat adults with certain types of large B-cell lymphoma who have not responded to or who have relapsed after standard treatments. The approval was supported by research at Seattle Children’s, including the […]

Read More →